Syndactyly-nystagmus syndrome due to 2q31.1 microduplication

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Syndactyly-nystagmus syndrome due to 2q31.1 microduplication
Synonyms
Pronounce
Specialty	Medical genetics
Symptoms	Syndactyly, nystagmus, developmental delay
Complications	N/A
Onset
Duration
Types
Causes	2q31.1 microduplication
Risks
Diagnosis	Genetic testing
Differential diagnosis
Prevention
Treatment	Supportive care
Medication
Prognosis
Frequency
Deaths	N/A

Rare genetic disorder

Syndactyly-nystagmus syndrome due to 2q31.1 microduplication is a rare genetic disorder characterized by the presence of syndactyly, nystagmus, and other developmental anomalies. This condition is associated with a microduplication on chromosome 2q31.1, which affects the normal development of various bodily systems.

Genetic Basis

The syndrome is caused by a microduplication at the 2q31.1 locus on chromosome 2. This genetic alteration involves the duplication of a small segment of DNA, which can disrupt the normal function of genes located in this region. The condition is typically inherited in an autosomal dominant manner, meaning that a single copy of the duplicated segment is sufficient to cause the disorder.

Clinical Features

Individuals with this syndrome often present with a combination of physical and neurological symptoms. The most common features include:

• Syndactyly: Fusion of two or more fingers or toes, which can vary in severity from partial to complete fusion.
• Nystagmus: Involuntary eye movements that can affect vision and coordination.
• Developmental Delay: Some individuals may experience delays in reaching developmental milestones, such as walking or speaking.
• Craniofacial Anomalies: These may include a high forehead, broad nasal bridge, and other facial dysmorphisms.

Diagnosis

Diagnosis of syndactyly-nystagmus syndrome due to 2q31.1 microduplication is typically made through genetic testing. Chromosomal microarray analysis can identify the presence of the microduplication, confirming the diagnosis. Clinical evaluation by a geneticist may also be necessary to assess the full spectrum of symptoms and associated anomalies.

Management

Management of this syndrome is symptomatic and supportive. Treatment may involve:

• Surgical Intervention: To correct syndactyly and improve hand or foot function.
• Vision Therapy: To address nystagmus and improve visual acuity.
• Developmental Support: Including physical, occupational, and speech therapy to assist with developmental delays.

Prognosis

The prognosis for individuals with this syndrome varies depending on the severity of symptoms and the presence of additional complications. Early intervention and supportive therapies can improve quality of life and functional outcomes.

See also

• Syndactyly
• Nystagmus
• Chromosomal microduplication
• Autosomal dominant disorder